endocrinology
Type 2 diabetes

Semaglutide on the PBS for type 2 diabetes

Another GLP-1 receptor agonist semaglutide (Ozempic) is now on the PBS as a treatment option for patients with insufficiently controlled type 2 diabetes. The once-weekly glucose-lowering treatment is preferentially used as second and third line treatment in type 2 diabetes, particularly for patients at high risk of cardiovascular disease and in patients who are overweight ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic